Sort
11,323 grants matching “glioblastoma”
MRI Assessment of Glucose Metabolism in Brain Tumor Using GlucoCEST
$202,000Wai Yan Chan · Hugo W. Moser Res Inst Kennedy Krieger · R21 · FY2015 · EB
Screening for novel inhibitors of Glutathione Peroxidase 1 and 4
$201,957Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Identification of small molecule inhibitors of USP15
$201,957Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Core--Nucleic acid quantitation
$201,875Samuel D Rabkin · Massachusetts General Hospital · P30 · FY2007 · NS
Reprogramming the Human Glioma Genome
$201,875Chun-Li Zhang · Ut Southwestern Medical Center · R21 · FY2015 · NS
Transcribed Ultra Conserved Regions in Glioblastoma
$201,875Roger Abounader · University Of Virginia · R21 · FY2022 · NS
Functional analysis of pathogenic mutations in Neurofibromatosis Type-1 (NF1)
$201,725James Anthony Walker · Massachusetts General Hospital · R21 · FY2017 · NS
Targeted nanotechnology for the pancreatic tumor immune microenvironment
$201,715Martin G Pomper · Ut Southwestern Medical Center · P41 · FY2025 · EB
Exploiting Altered Porphyrin Synthesis for Metabolic Imaging of Glioblastoma
$201,623Dirk Mayer · University Of Maryland Baltimore · R21 · FY2017 · CA
MR Imaging of IDH Mutational Status in Brain Tumors
$201,623Sabrina Miriam Ronen · University Of California, San Francisco · R21 · FY2012 · CA
Microvesicles as potential genetic biomarkers of brain tumors
$201,599Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2014 · CA
TUMOR-TARGETING WITH NEW BORONATED PORPHYRINS
$201,520Maria Da Graca Henriques Vicente · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2010 · CA
Image-guided, ultrasound-enhanced long-term intracranial drug delivery
$201,516Yevgeny Brudno · North Carolina State University Raleigh · R21 · FY2021 · CA
Opioid-induced changes to chemotherapeutic activity in blood cancer
$201,457Jonathan Eric Constance · University Of Utah · K22 · FY2023 · CA
Opioid-induced changes to chemotherapeutic activity in blood cancer
$201,134Jonathan Eric Constance · University Of Utah · K22 · FY2024 · CA
Cell invasion, motility, and proliferation level estimate maps in gliomas
$200,971Benjamin M. Ellingson · University Of California Los Angeles · R21 · FY2012 · CA
Common hTERT Promoter Mutations Represent a Novel Therapeutic Target
$200,970Donald M Miller · University Of Louisville · R21 · FY2017 · CA
MicroRNA and Transcription Factor Co-regulation in Cancer
$200,970Zhongming Zhao · University Of Texas Hlth Sci Ctr Houston · R21 · FY2017 · CA
Inhibition of Autophagy Enhances Anti-Angiogenic Efficacy in Intracranial Glioma
$200,970Martin M Pike · Oregon Health & Science University · R21 · FY2012 · CA
Identifying vulnerabilities and therapeutic targets in Glioma Stem Cells
$200,880Christian Elias Badr · Massachusetts General Hospital · K22 · FY2016 · CA
Identifying vulnerabilities and therapeutic targets in Glioma Stem Cells
$200,880Christian Elias Badr · Massachusetts General Hospital · K22 · FY2015 · CA
Identifying vulnerabilities and therapeutic targets in Glioma Stem Cells
$200,880Christian Elias Badr · Massachusetts General Hospital · K22 · FY2017 · CA
Microvesicles as potential genetic biomarkers of brain tumors
$200,700Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2013 · CA
Regulation of glioblastoma migration by PTEN PDZ-binding domain
$200,640Andrew M Chan · Medical College Of Wisconsin · R21 · FY2010 · CA
Exploiting chemoimmunotherapy strategies with genetically-engineered gd T cells
$200,637Kelly C Goldsmith · Emory University · R21 · FY2018 · CA